The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines helped control the spread of the virus, the emergence of new variants continues ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations that increased transmissibility or helped the virus evade our immune ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

Having this knowledge from our model would help with readiness for detecting ... SARS-CoV-2 variants with human host cells, Momeni said. The spike protein of the coronavirus, or SARS-CoV-2, binds to ...

Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before ... Subscribe for FREE Many of these key mutations are in the spike protein, ...

such as those for the spike protein, inserting the blueprints into DNA, RNA or a safe virus and injecting those into people. The Remarkable and Mysterious Coronavirus Genome The SARS-CoV-2 genome ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...